APA (7th ed.) Citation

J, L., F, L., Q, Z., W, H., L, Y., S, L., . . . Y, D. (2026). Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control. Drug design, development and therapy, 20, 610273. https://doi.org/10.2147/DDDT.S610273

Chicago Style (17th ed.) Citation

J, Liu, Li F, Zeng Q, Hu W, Yang L, Luo S, Lv F, Li D, and Deng Y. "Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control." Drug Design, Development and Therapy 20 (2026): 610273. https://doi.org/10.2147/DDDT.S610273.

MLA (9th ed.) Citation

J, Liu, et al. "Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control." Drug Design, Development and Therapy, vol. 20, 2026, p. 610273, https://doi.org/10.2147/DDDT.S610273.